<unk>  is a platelet reducing agent that is FDA approved for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms.   Common adverse reactions include .
Anagrelide
Niclosamide
Etamiphylline
Peginesatide
Abciximab
Pentoxifylline
Gadoteric acid
Picloxydine